Cargando…

Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study

Objective To examine the effect of systolic and diastolic blood pressure achieved in the first year of treatment on all cause mortality in patients newly diagnosed with type 2 diabetes, with and without established cardiovascular disease. Design Retrospective cohort study. Setting United Kingdom Gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Vamos, Eszter Panna, Harris, Matthew, Millett, Christopher, Pape, Utz J, Khunti, Kamlesh, Curcin, Vasa, Molokhia, Mariam, Majeed, Azeem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431284/
https://www.ncbi.nlm.nih.gov/pubmed/22936794
http://dx.doi.org/10.1136/bmj.e5567
_version_ 1782242055704018944
author Vamos, Eszter Panna
Harris, Matthew
Millett, Christopher
Pape, Utz J
Khunti, Kamlesh
Curcin, Vasa
Molokhia, Mariam
Majeed, Azeem
author_facet Vamos, Eszter Panna
Harris, Matthew
Millett, Christopher
Pape, Utz J
Khunti, Kamlesh
Curcin, Vasa
Molokhia, Mariam
Majeed, Azeem
author_sort Vamos, Eszter Panna
collection PubMed
description Objective To examine the effect of systolic and diastolic blood pressure achieved in the first year of treatment on all cause mortality in patients newly diagnosed with type 2 diabetes, with and without established cardiovascular disease. Design Retrospective cohort study. Setting United Kingdom General Practice Research Database, between 1990 and 2005. Participants 126 092 adult patients (age ≥18 years) with a new diagnosis of type 2 diabetes who had been registered with participating practices for at least 12 months. Main outcome measure All cause mortality. Results Before diagnosis, 12 379 (9.8%) patients had established cardiovascular disease (myocardial infarction or stroke). During a median follow-up of 3.5 years, we recorded 25 495 (20.2%) deaths. In people with cardiovascular disease, tight control of systolic (<130 mm Hg) and diastolic (<80 mm Hg) blood pressure was not associated with improved survival, after adjustment for baseline characteristics (age at diagnosis, sex, practice level clustering, deprivation score, body mass index, smoking, HbA(1c) and cholesterol levels, and blood pressure). Low blood pressure was also associated with an increased risk of all cause mortality. Compared with patients who received usual control of systolic blood pressure (130-139 mm Hg), the hazard ratio of all cause mortality was 2.79 (95% confidence interval 1.74 to 4.48, P<0.001) for systolic blood pressure at 110 mm Hg. Compared with patients who received usual control of diastolic blood pressure (80-84 mm Hg), the hazard ratios were 1.32 (1.02 to 1.78, P=0.04) and 1.89 (1.40 to 2.56, P<0.001) for diastolic blood pressures at 70-74 mm Hg and lower than 70 mm Hg, respectively. Similar associations were found in people without cardiovascular disease. Subgroup analyses of people diagnosed with hypertension and who received treatment for hypertension confirmed initial findings. Conclusion Blood pressure below 130/80 mm Hg was not associated with reduced risk of all cause mortality in patients with newly diagnosed diabetes, with or without known cardiovascular disease. Low blood pressure, particularly below 110/75 mm Hg, was associated with an increased risk for poor outcomes.
format Online
Article
Text
id pubmed-3431284
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-34312842012-08-31 Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study Vamos, Eszter Panna Harris, Matthew Millett, Christopher Pape, Utz J Khunti, Kamlesh Curcin, Vasa Molokhia, Mariam Majeed, Azeem BMJ Research Objective To examine the effect of systolic and diastolic blood pressure achieved in the first year of treatment on all cause mortality in patients newly diagnosed with type 2 diabetes, with and without established cardiovascular disease. Design Retrospective cohort study. Setting United Kingdom General Practice Research Database, between 1990 and 2005. Participants 126 092 adult patients (age ≥18 years) with a new diagnosis of type 2 diabetes who had been registered with participating practices for at least 12 months. Main outcome measure All cause mortality. Results Before diagnosis, 12 379 (9.8%) patients had established cardiovascular disease (myocardial infarction or stroke). During a median follow-up of 3.5 years, we recorded 25 495 (20.2%) deaths. In people with cardiovascular disease, tight control of systolic (<130 mm Hg) and diastolic (<80 mm Hg) blood pressure was not associated with improved survival, after adjustment for baseline characteristics (age at diagnosis, sex, practice level clustering, deprivation score, body mass index, smoking, HbA(1c) and cholesterol levels, and blood pressure). Low blood pressure was also associated with an increased risk of all cause mortality. Compared with patients who received usual control of systolic blood pressure (130-139 mm Hg), the hazard ratio of all cause mortality was 2.79 (95% confidence interval 1.74 to 4.48, P<0.001) for systolic blood pressure at 110 mm Hg. Compared with patients who received usual control of diastolic blood pressure (80-84 mm Hg), the hazard ratios were 1.32 (1.02 to 1.78, P=0.04) and 1.89 (1.40 to 2.56, P<0.001) for diastolic blood pressures at 70-74 mm Hg and lower than 70 mm Hg, respectively. Similar associations were found in people without cardiovascular disease. Subgroup analyses of people diagnosed with hypertension and who received treatment for hypertension confirmed initial findings. Conclusion Blood pressure below 130/80 mm Hg was not associated with reduced risk of all cause mortality in patients with newly diagnosed diabetes, with or without known cardiovascular disease. Low blood pressure, particularly below 110/75 mm Hg, was associated with an increased risk for poor outcomes. BMJ Publishing Group Ltd. 2012-08-30 /pmc/articles/PMC3431284/ /pubmed/22936794 http://dx.doi.org/10.1136/bmj.e5567 Text en © Vamos et al 2012 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Research
Vamos, Eszter Panna
Harris, Matthew
Millett, Christopher
Pape, Utz J
Khunti, Kamlesh
Curcin, Vasa
Molokhia, Mariam
Majeed, Azeem
Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study
title Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study
title_full Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study
title_fullStr Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study
title_full_unstemmed Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study
title_short Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study
title_sort association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431284/
https://www.ncbi.nlm.nih.gov/pubmed/22936794
http://dx.doi.org/10.1136/bmj.e5567
work_keys_str_mv AT vamoseszterpanna associationofsystolicanddiastolicbloodpressureandallcausemortalityinpeoplewithnewlydiagnosedtype2diabetesretrospectivecohortstudy
AT harrismatthew associationofsystolicanddiastolicbloodpressureandallcausemortalityinpeoplewithnewlydiagnosedtype2diabetesretrospectivecohortstudy
AT millettchristopher associationofsystolicanddiastolicbloodpressureandallcausemortalityinpeoplewithnewlydiagnosedtype2diabetesretrospectivecohortstudy
AT papeutzj associationofsystolicanddiastolicbloodpressureandallcausemortalityinpeoplewithnewlydiagnosedtype2diabetesretrospectivecohortstudy
AT khuntikamlesh associationofsystolicanddiastolicbloodpressureandallcausemortalityinpeoplewithnewlydiagnosedtype2diabetesretrospectivecohortstudy
AT curcinvasa associationofsystolicanddiastolicbloodpressureandallcausemortalityinpeoplewithnewlydiagnosedtype2diabetesretrospectivecohortstudy
AT molokhiamariam associationofsystolicanddiastolicbloodpressureandallcausemortalityinpeoplewithnewlydiagnosedtype2diabetesretrospectivecohortstudy
AT majeedazeem associationofsystolicanddiastolicbloodpressureandallcausemortalityinpeoplewithnewlydiagnosedtype2diabetesretrospectivecohortstudy